{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:28:31Z","timestamp":1790720911615,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,6]],"date-time":"2021-02-06T00:00:00Z","timestamp":1612569600000},"content-version":"am","delay-in-days":371,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.gofs.2020.01.001","type":"journal-article","created":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T16:56:24Z","timestamp":1578502584000},"page":"181-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["La spironolactone en relais de l\u2019ac\u00e9tate de cyprot\u00e9rone dans l\u2019hyperandrog\u00e9nie f\u00e9minine"],"prefix":"10.1016","volume":"48","author":[{"given":"E.","family":"Broux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Dewailly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Catteau-Jonard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.gofs.2020.01.001_bib0150","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jc.2003-031122","article-title":"Androgen excess in women: experience with over 1000 consecutive patients","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.gofs.2020.01.001_bib0155","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.lpm.2013.07.016","article-title":"Hyperandrog\u00e9nie f\u00e9minine","volume":"42","author":"Peign\u00e9","year":"2013","journal-title":"Presse M\u00e9dicale"},{"issue":"2","key":"10.1016\/j.gofs.2020.01.001_bib0160","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/humupd\/dmr042","article-title":"Epidemiology, diagnosis and management of hirsutism: a consensus statement by the androgen excess and polycystic ovary syndrome society","volume":"18","author":"Escobar-Morreale","year":"2012","journal-title":"Hum Reprod Update"},{"issue":"1","key":"10.1016\/j.gofs.2020.01.001_bib0165","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ando.2009.12.001","article-title":"Anti-androgen Treatments","volume":"71","author":"Bachelot","year":"2010","journal-title":"Ann Endocrinol"},{"issue":"7.","key":"10.1016\/j.gofs.2020.01.001_bib0170","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004425.pub5","article-title":"Combined oral contraceptive pills for treatment of acne","author":"Arowojolu","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.gofs.2020.01.001_bib0175","article-title":"Does cyproterone acetate promote multiples meningiomas","author":"Froelich","year":"2008","journal-title":"European Congress of Endocrinology"},{"issue":"10","key":"10.1016\/j.gofs.2020.01.001_bib0180","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s00701-015-2532-3","article-title":"Growth stabilization and regression of meningiomas after discontinuation of cyproterone acetate: a case series of 12 patients","volume":"157","author":"Bernat","year":"2015","journal-title":"Acta Neurochir (Wien)"},{"issue":"6","key":"10.1016\/j.gofs.2020.01.001_bib0185","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1365-2125.2011.04031.x","article-title":"Risk of meningioma among users of high doses of cyproterone acetate as compared with the general population: evidence from a population-based cohort study","volume":"72","author":"Gil","year":"2011","journal-title":"Br J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.gofs.2020.01.001_bib0190","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.annder.2018.04.001","article-title":"M\u00e9ningiomes et ac\u00e9tate de cyprot\u00e9rone: mise au point","volume":"145","author":"Schmutz","year":"2018","journal-title":"Ann Dermatol V\u00e9n\u00e9r\u00e9ologie"},{"issue":"5","key":"10.1016\/j.gofs.2020.01.001_bib0195","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.clindermatol.2004.03.010","article-title":"Acne: hormonal concepts and therapy","volume":"22","author":"Thiboutot","year":"2004","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.gofs.2020.01.001_bib0200","first-page":"54","article-title":"Spironolactone versus placebo or in combination with steroids for hirsutism and\/or acne","author":"Brown","year":"2009","journal-title":"Cochrane Libr"},{"issue":"4","key":"10.1016\/j.gofs.2020.01.001_bib0205","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1210\/jc.2017-02052","article-title":"Treatment options for hirsutism: a systematic review and network meta-analysis","volume":"103","author":"Barrionuevo","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.gofs.2020.01.001_bib0210","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"The Rotterdam ESHRE\/ASRM-sponsored PCOS consensus workshop group","year":"2004","journal-title":"Hum Reprod"},{"issue":"3","key":"10.1016\/j.gofs.2020.01.001_bib0215","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/09546634.2010.519766","article-title":"Cyproterone acetate or drospirenone containing combined oral contraceptives plus spironolactone or cyproterone acetate for hirsutism: randomized comparison of three regimens","volume":"23","author":"Kelekci","year":"2012","journal-title":"J Dermatol Treat"},{"key":"10.1016\/j.gofs.2020.01.001_bib0220","article-title":"Comparison of the efficiency of anti-androgenic regimens consisting of spironolactone, Diane 35, and cyproterone acetate in hirsutism","author":"Sert","year":"2003","journal-title":"Acta Medica Okayama"},{"issue":"2","key":"10.1016\/j.gofs.2020.01.001_bib0225","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0190-9622(91)70034-Y","article-title":"Spironolactone in dermatologic therapy","volume":"24","author":"Shaw","year":"1991","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.gofs.2020.01.001_bib0230","first-page":"89","article-title":"Comparison of spironolactone, flutamide, and finasteride efficacy in the treatment of hirsutism: a randomized, double blind, placebo-controlled trial1","volume":"85","author":"Moghetti","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.gofs.2020.01.001_bib0235","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s40257-016-0245-x","article-title":"Oral spironolactone for acne vulgaris in adult females: a hybrid systematic review","volume":"18","author":"Layton","year":"2017","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"10.1016\/j.gofs.2020.01.001_bib0240","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1468-3083.2005.01072.x","article-title":"Effects and side-effects of spironolactone therapy in women with acne","volume":"19","author":"Yemisci","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.gofs.2020.01.001_bib0245","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1067\/mjd.2000.105557","article-title":"Low-dose adjunctive spironolactone in the treatment of acne in women: A retrospective analysis of 85 consecutively treated patients","volume":"43","author":"Shaw","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.gofs.2020.01.001_bib0250","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2133.2005.06218.x","article-title":"Treatment of female pattern hair loss with oral antiandrogens","volume":"152","author":"Sinclair","year":"2005","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.gofs.2020.01.001_bib0255","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1210\/jc.2007-2430","article-title":"Antiandrogens for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials","volume":"93","author":"Swiglo","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.gofs.2020.01.001_bib0260","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.det.2010.03.011","article-title":"Innovative use of spironolactone as an antiandrogen in the treatment of female pattern hair loss","volume":"28","author":"Rathnayake","year":"2010","journal-title":"Dermatol Clin"},{"issue":"2","key":"10.1016\/j.gofs.2020.01.001_bib0265","first-page":"271","article-title":"Polycystic ovary syndrome and weight management","volume":"6","author":"Moran","year":"2010","journal-title":"Womens Health"},{"issue":"1 Suppl","key":"10.1016\/j.gofs.2020.01.001_bib0270","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1016\/j.ijwd.2017.02.007","article-title":"Endocrine evaluation of hirsutism","volume":"3","author":"Mihailidis","year":"2017","journal-title":"Int J Womens Dermatol"},{"issue":"6","key":"10.1016\/j.gofs.2020.01.001_bib0275","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1177\/120347540200600604","article-title":"Long-term safety of spironolactone in acne: results of an 8-year follow-up study","volume":"6","author":"Shaw","year":"2002","journal-title":"J Cutan Med Surg"},{"issue":"5","key":"10.1016\/j.gofs.2020.01.001_bib0280","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1365-2133.1988.tb02571.x","article-title":"Tolerance of spironolactone","volume":"118","author":"Hughes","year":"1988","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.gofs.2020.01.001_bib0285","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1210\/jcem-66-1-208","article-title":"Side-effects of spironolactone therapy in the hirsute woman","volume":"66","author":"Helfer","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.gofs.2020.01.001_bib0290","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/jamadermatol.2015.34","article-title":"Low usefulness of potassium monitoring among healthy young women taking spironolactone for acne","volume":"151","author":"Plovanich","year":"2015","journal-title":"JAMA Dermatol"}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718920300015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718920300015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:39:01Z","timestamp":1762853941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468718920300015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S2468718920300015"],"URL":"https:\/\/doi.org\/10.1016\/j.gofs.2020.01.001","relation":{},"ISSN":["2468-7189"],"issn-type":[{"value":"2468-7189","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"La spironolactone en relais de l\u2019ac\u00e9tate de cyprot\u00e9rone dans l\u2019hyperandrog\u00e9nie f\u00e9minine","name":"articletitle","label":"Article Title"},{"value":"Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2020.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}